INSIGHTS ON DRUG DEVELOPMENT
-
Bridging The Gap Between Traditional Models And Human Biology
Whether you are new to Organ-on-a-Chip technology or seeking to expand your expertise, watch to gain the knowledge and insights needed to effectively implement this technology into your research.
-
Mitigating Early Development Risks
Discover how the efficient screening of biologic candidates accelerates the discovery process, reduces costs, and improves the likelihood of commercializing safe and effective drugs.
-
Assessment Of Compound Toxicity Effects With High-Content Imaging
3D cellular models and bioprinting enhance drug safety predictions and offer precise spatial control. Explore an automated method for generating liver models to improve reproducibility and reliability in toxicity testing.
-
Are You Keeping Pace With Oligo Synthesis Optimization?
The rapidly expanding oligo market demands optimized RNA synthesis. Examine key innovations and workflow insights to maximize resources and control long-term manufacturing costs.
-
Maintain Control Of Pharmaceutical Water Systems4/10/2026
Early TOC excursions often reveal hidden risks in water systems. Capturing samples at the moment of deviation helps teams confirm root causes faster, reduce uncertainty, and maintain control.
-
Automation Of 3D Intestinal Organoids Culture3/17/2025
Gain insight into how 3D organoids promise better disease modeling and drug screening and how challenges like assay complexity, reproducibility, and scalability hinder their widespread adoption in drug discovery.
-
Spray Dried Biologics For Pulmonary Dosage Forms5/8/2026
View how spray drying enables stable, precisely engineered pulmonary powders for biologics, supporting efficient lung delivery, scalability, and preservation of molecular structure and activity.
-
Simplify Process Scale-Up With An Innovative Single-Use Bioreactor10/15/2025
Consistent cell growth and protein yields from 5 L to 5,000 L show how a unified bioreactor design can simplify scale-up, reduce risk, and accelerate upstream process development in bioproduction.
-
5 Key Considerations For Companies Outsourcing Process Development6/9/2025
Venture capital in biotech remains strong post-pandemic, especially in cell and gene therapies. Discover five key factors to help companies choose between in-house and outsourced process development strategies.
DRUG DEVELOPMENT SOLUTIONS
-
Tailored support is available for diverse molecules, including small and large molecules, nucleic acid therapies, and novel delivery systems. Services span drug substance to regulatory affairs.
-
Our integrated approach brings together drug substance, drug product and clinical activities, supporting the expediting of lead molecules from FIH into POC trials.
-
From cancer models to high-throughput screening, Organ-Chip platforms accelerate development, improve safety, and support regulatory compliance for next-generation therapies.
-
Leica M125 C Encoded Stereo Microscopes
Total recall of your settings
Your goal: high-quality images that allow measurements and can be accurately repeated with minimal effort. The Leica coded stereo microscopes help you to pave the way to correct results.
- Coded microscopes consistently deliver calibrated and comparable images
- Reproduce images in moments with the Leica “Store and Recall” function
- Fully apochromatic corrected zoom optics deliver high quality images
- Customize the microscope system to your task with the exclusive range of accessories
-
Decades of experience in production technologies, quality control and knowledge of the regulatory environment result in high-quality drug delivery devices that are fully optimized to perform as a system.